Research Article| Volume 43, ISSUE 1, P9-17, February 2020

Download started.


Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update

Published:November 21, 2019DOI:



      A survey in 2015 identified a high level of eye care practitioner concern about myopia with a reported moderately high level of activity, but the vast majority still prescribed single vision interventions to young myopes. This research aimed to update these findings 4 years later.


      A self-administrated, internet-based questionnaire was distributed in eight languages, through professional bodies to eye care practitioners globally. The questions examined: awareness of increasing myopia prevalence, perceived efficacy of available strategies and adoption levels of such strategies, and reasons for not adopting specific strategies.


      Of the 1336 respondents, concern was highest (9.0 ± 1.6; p < 0.001) in Asia and lowest (7.6 ± 2.2; p < 0.001) in Australasia. Practitioners from Asia also considered their clinical practice of myopia control to be the most active (7.7 ± 2.3; p < 0.001), the North American practitioners being the least active (6.3 ± 2.9; p < 0.001). Orthokeratology was perceived to be the most effective method of myopia control, followed by pharmaceutical approaches and approved myopia control soft contact lenses (p < 0.001). Although significant intra-regional differences existed, overall, most practitioners did not consider single-vision distance under-correction to be an effective strategy for attenuating myopia progression (79.6 %), but prescribed single vision spectacles or contact lenses as the primary mode of correction for myopic patients (63.6 ± 21.8 %). The main justifications for their reluctance to prescribe alternatives to single vision refractive corrections were increased cost (20.6 %) and inadequate information (17.6 %).


      While practitioner concern about myopia and the reported level of activity have increased over the last 4 years, the vast majority of eye care clinicians still prescribe single vision interventions to young myopes. With recent global consensus evidence-based guidelines having been published, it is hoped that this will inform the practice of myopia management in future.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contact Lens and Anterior Eye
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Holden B.A.
        • Fricke T.R.
        • Wilson D.A.
        • et al.
        Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050.
        Ophthalmology. 2016; 123: 1036-1042
        • Wolffsohn J.S.
        • Flitcroft D.I.
        • Gifford K.L.
        • et al.
        IMI – myopia control reports overview and introduction.
        Invest Ophthalmol Vis Sci. 2019; 60: M1-M19
        • Flitcroft D.I.
        • He M.
        • Jonas J.B.
        • et al.
        IMI – defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies.
        Invest Ophthalmol Vis Sci. 2019; 60: M20-30
        • Troilo D.
        • Smith I.I.I.E.L.
        • Nickla D.L.
        • et al.
        IMI – report on experimental models of emmetropization and myopia.
        Invest Ophthalmol Vis Sci. 2019; 60: M31-88
        • Tedja M.S.
        • Haarman A.E.G.
        • Meester-Smoor M.A.
        • for the CREAM Consortium
        • et al.
        IMI – myopia genetics report.
        Invest Ophthalmol Vis Sci. 2019; 60: M89-105
        • Wildsoet C.F.
        • Chia A.
        • Cho P.
        • et al.
        IMI – interventions for controlling myopia onset and progression report.
        Invest Ophthalmol Vis Sci. 2019; 60: M106-131
        • Wolffsohn J.S.
        • Kollbaum P.S.
        • Berntsen D.A.
        • et al.
        IMI – clinical myopia control trials and instrumentation report.
        Invest Ophthalmol Vis Sci. 2019; 60: M132-160
        • Jones L.
        • Drobe B.
        • Gonzalez-Meijome J.M.
        • et al.
        IMI – industry guidelines and ethical considerations for myopia control report.
        Invest Ophthalmol Vis Sci. 2019; 60: M161-183
        • Gifford K.L.
        • Richdale K.
        • Kang P.
        • et al.
        IMI – clinical management guidelines report.
        Invest Ophthalmol Vis Sci. 2019; 60: M184-203
        • Jung J.J.
        • Lim E.H.
        • Baek S.H.
        • Kim Y.R.
        • Gong S.M.
        • Kim U.S.
        Attempts to reduce the progression of myopia and spectacle prescriptions during childhood: a survey of eye specialists.
        Korean J Ophthalmol. 2011; 25: 417-420
        • Zloto O.
        • Wygnanski-Jaffe T.
        • Farzavandi S.K.
        • Gomez-de-Liano R.
        • Sprunger D.T.
        • Mezer E.
        Current trends among pediatric ophthalmologists to decrease myopia progression-an international perspective.
        Graefes Arch Clin Exp Ophthalmol. 2018; 256: 2457-2466
        • Wolffsohn J.S.
        • Calossi A.
        • Cho P.
        • et al.
        Global trends in myopia management attitudes and strategies in clinical practice.
        Cont Lens Anterior Eye. 2016; 39: 106-116
        • Montes-Mico R.
        • Ferrer-Blasco T.
        Distribution of refractive errors in Spain.
        Doc Ophthalmol. 2000; 101: 25-33
        • Jorge J.
        • Almeida J.B.
        • Parafita M.A.
        Refractive, biometric and topographic changes among Portuguese university science students: a 3-year longitudinal study.
        Ophthalmic Physiol Opt. 2007; 27: 287-294
        • McCullough S.J.
        • O’Donoghue L.
        • Saunders K.J.
        Six year refractive change among white children and young adults: evidence for significant increase in myopia among white UK children.
        PLoS One. 2016;
        • Hendricks T.J.W.
        • de Brabander J.
        • Vankan-Hendricks M.H.P.
        • Van Der Horst F.G.
        • Hendrikse F.
        • Knottnerus J.A.
        Prevalence of habitual refractive errors and anisometropia among Dutch schoolchildren and hospital employees.
        Acta Ophthalmol. 2009; 87: 538-543
        • Vitale S.
        • Sperduto R.D.
        • Ferris F.L.
        Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004.
        Arch Ophthalmol. 2009; 127: 1632-1639
        • Yang M.
        • Luensmann D.
        • Fonn D.
        • et al.
        Myopia prevalence in Canadian school children: a pilot study.
        Eye (Lond). 2018; 32: 1042-1047
        • Chung K.
        • Mohidin N.
        • O’Leary D.J.
        Undercorrection of myopia enhances rather than inhibits myopia progression.
        Vision Res. 2002; 42: 2555-2559
        • Adler D.
        • Millodot M.
        The possible effect of undercorrection on myopic progression in children.
        Clin Exp Optom. 2006; 89: 315-321
        • Mutti D.O.
        • Sinnott L.T.
        • Mitchell G.L.
        • et al.
        Relative peripheral refractive error and the risk of onset and progression of myopia in children.
        Invest Ophthalmol Vis Sci. 2011; 52: 199-205
        • Atchison D.A.
        • Li S.-M.
        • Li H.
        • et al.
        Relative peripheral hyperopia does not predict development and progression of myopia in children.
        Invest Ophthalmol Vis Sci. 2015; 56: 6162-6170
        • Zadnik K.
        • Sinnott L.T.
        • Cotter S.A.
        • et al.
        Prediction of juvenile-onset myopia.
        JAMA Ophthalmol. 2015; 133: 683-689
        • Cho P.
        • Tan Q.
        Myopia and orthokeratology for myopia control.
        Clin Exp Optom. 2019; 102: 364-377
        • Dong L.M.
        • Fazzari M.
        • Gwiazda J.
        • et al.
        Myopia stabilization and associated factors among participants in the Correction of Myopia Evaluation Trial (COMET).
        Invest Ophthalmol Vis Sci. 2013; 54: 7871-7883
        • Thorn F.
        • Gwiazda J.
        • Held R.
        Myopia progression is specified by a double exponential growth function.
        Optom Vis Sci. 2005; 82: 286-297
        • Saw S.M.
        • Gazzard G.
        • Shih-Yen E.C.
        • Chua W.H.
        Myopia and associated pathological complications.
        Ophthalmic Physiol Opt. 2005; 25: 381-391